FDA Warns Not to Rely on Pulse Oximetry for Diagnosis, Treatment Decisions

TUESDAY, Feb. 23, 2021 -- The U.S. Food and Drug Administration is warning against reliance on pulse oximeters for diagnosis and treatment decisions for COVID-19 and other conditions. In a safety communication released Friday, the agency said that...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news